Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment
Clinical trial NCT06081595 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06081595
- Sponsor
- Jin Li
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-12-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.